1. Home
  2. KSS vs VCEL Comparison

KSS vs VCEL Comparison

Compare KSS & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kohl's Corporation

KSS

Kohl's Corporation

SELL

Current Price

$22.04

Market Cap

1.9B

ML Signal

SELL

Logo Vericel Corporation

VCEL

Vericel Corporation

SELL

Current Price

$41.06

Market Cap

2.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
KSS
VCEL
Founded
1962
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.1B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
KSS
VCEL
Price
$22.04
$41.06
Analyst Decision
Hold
Strong Buy
Analyst Count
14
8
Target Price
$18.88
★ $59.71
AVG Volume (30 Days)
★ 3.5M
504.6K
Earning Date
11-24-2026
11-05-2026
Dividend Yield
★ 2.36%
N/A
EPS Growth
★ 142.86
60.00
EPS
★ 1.18
N/A
Revenue
N/A
★ $276,259,000.00
Revenue This Year
N/A
$21.71
Revenue Next Year
$0.04
$16.86
P/E Ratio
$17.92
★ N/A
Revenue Growth
N/A
★ 16.45
52 Week Low
$11.38
$28.95
52 Week High
$25.22
$49.32

Technical Indicators

Market Signals
Indicator
KSS
VCEL
Relative Strength Index (RSI) 75.31 54.13
Support Level $16.19 $37.78
Resistance Level N/A $41.21
Average True Range (ATR) 0.89 1.23
MACD 0.33 0.17
Stochastic Oscillator 99.32 84.90

Price Performance

Historical Comparison
KSS
VCEL

About KSS Kohl's Corporation

Kohl's is the second-largest traditional US department store company by sales. It has about 1,150 stores in 49 states and offers moderately priced private-label (31% of 2025 sales) and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most (about 80%) of its stores are in strip centers. Kohl's also has a large digital sales operation (29% of 2025 sales). Women's apparel is the retailer's largest category, having generated 24% of its 2025 sales. Kohl's is headquartered in Menomonee Falls, Wisconsin, and was founded in 1962.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: